Last updated on November 2016

A Phase 3 Clinical Trial for Patients with Moderately to Severely Active Crohn's Disease.


Brief description of study

A Phase 3 Clinical Trial for Patients with Moderately to Severely Active Crohn's Disease.

Detailed Study Description

The purpose of this study is to assess the effect of vedolizumab in the subcutaneous form.

Clinical Study Identifier: TX15247

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

West Michigan Clinical Research Center

West Michigan Clinical Research Center
Wyoming, MI USA
  Connect »